Overview

Evolocumab Pregnancy Exposure Registry

Status:
Terminated
Trial end date:
2020-09-02
Target enrollment:
Participant gender:
Summary
This is a prospective observational registry study to evaluate fetal, infant and childhood outcomes in women exposed to evolocumab during pregnancy
Details
Lead Sponsor:
Amgen
Collaborator:
Organization of Teratology Information Specialists (OTIS) Research Center - tel: 1-866-626-6847 or www.mothertobaby.org
Treatments:
Evolocumab